UK markets closed

Hemogenyx Pharmaceuticals Plc (HEMO.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.6380+0.0230 (+1.42%)
At close: 04:23PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Cost of revenue
421.817
2,197
283.647
267.057
Gross profit
-421.817
-2,197
-283.647
-267.057
Operating expenses
Selling general and administrative
4,131
1,345
1,397
711.723
Total operating expenses
6,407
3,334
2,547
1,949
Operating income or loss
-8,603
-5,530
-2,831
-2,216
Interest expense
162.055
0.033
2,595
33.239
Income before tax
-7,169
-3,987
-5,108
-2,095
Income tax expense
-35
0
0
0
Income from continuing operations
-7,169
-3,987
-5,108
-2,095
Net income
-7,173
-3,979
-5,099
-2,082
Net income available to common shareholders
-7,173
-3,979
-5,099
-2,082
Basic EPS
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.01
Basic average shares
1,114,235
979,749
773,952
414,833
Diluted average shares
1,114,235
979,749
773,952
414,833